Epoprostenol Sodium
규격
61849-14-7CAS 번호
263-273-7EC 번호
sodium (5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoateIUPAC 명칭
C20H31NaO5화학식
374.4 g/mol분자량
Epoprostenol sodium; 61849-14-7; Prostacyclin sodium salt; Cyclo-Prostin; Sodium prostacyclin; DTXSID3046617; 4K04IQ1OF4; U-53217A; U-53,217A; DTXCID1026617; Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, sodium salt, (5Z,9alpha,11alpha,13E,15S)-; RefChem:57240; 263-273-7; Sodium(Z)-(3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerate; Flolan; Prostacyclin sodium; Sodium (Z)-5-((3aR,4R,5R,6aS)-5-hydroxy-4-((S,E)-3-hydroxyoct-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-ylidene)pentanoate; C20H31NaO5; sodium;(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate; Epoprostenol sodium [USAN:BAN]; NCGC00167427-01; EINECS 263-273-7; UNII-4K04IQ1OF4; U 53,217A; Epoprostenolsodium; (5Z,9?,11?,13E,15S)-6,9-epoxy-11,15-Dihydroxy-prosta-5,13-dien-1-oic Acid Sodium Salt; Epoprostenol Sodium; Flolan;; Prostaglandin X sodium; Prostaglandin I2 sodium; PROSTAGLANDIN I2 Na; CHEMBL962; Sodium (5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dien-1-oate; SCHEMBL41344; Sodium (Z)-(3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerate; BML1-F10; orb1707331; Prostaglandin I2 (sodium salt); EX-A7849M; EPOPROSTENOL SODIUM [JAN]; 4UA76; EPOPROSTENOL SODIUM [USAN]; HMS1361K18; HMS3648L14; EPOPROSTENOL SODIUM [VANDF]; EPOPROSTENOL SODIUM [MART.]; Tox21_112431; EPOPROSTENOL SODIUM [USP-RS]; EPOPROSTENOL SODIUM [WHO-DD]; PROSTACYCLIN SODIUM SALT [MI]; AKOS024457370; EBC-127030; FP27241; EPOPROSTENOL SODIUM [ORANGE BOOK]; AC-38149; CAS-61849-14-7; NS00074283; T15238; Q27259818; (5Z,9a,11a,13E,15S)-6,9-epoxy-11,15-dihydroxy-prosta-5,13-dien-1-oic acid sodium; Sodium (5Z,13E,15S)-11beta,15-dihydroxy-9beta,12alpha-6,9-epoxyprosta-5,13-dien-1-oate; PROSTA-5,13-DIEN-1-OIC ACID, 6,9-EPOXY-11,15-DIHYDROXY-, SODIUM SALT, (5Z,9.ALPHA.,11.ALPHA.,13E,15S)-; SODIUM (Z)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-((E)-(3S)-3-HYDROXY-1-OCTENYL)-2H-CYCLOPENTA(B)FURAN-.DELTA.(SUP 2,.DELTA.)-VALERATE동의어
Epoprostenol Sodium 함유 제품
VELETRI 1,5 MG POLVO PARA SOLUCION PARA PERFUSIONVELETRI 0,5 MG POLVO PARA SOLUCION PARA PERFUSIONEPOPROSTENOL SUN 1,5 MG POLVO PARA SOLUCION PARA PERFUSIONVELETRI 1,5 MG POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSIONVELETRI 0,5 MG POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSIONFLOLAN 0,5 mg POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSIONVELETRI 1,5 mg, poudre et solvant pour solution pour perfusionVELETRI 0,5 mg, poudre et solvant pour solution pour perfusionEpoprostenol Sodium - Zhejiang Ausun PharmaceuticalEpoprostenol Sodium - MSN LaboratoriesEpoprostenol Sodium - Sun Pharmaceutical Industries LimitedEpoprostenol Sodium - EUROAPI
1/2 페이지
Epoprostenol Sodium 판매 기업
ML
MSN LaboratoriesIndiaZA
Zhejiang Ausun PharmaceuticalChinaSP
Sun Pharmaceutical Industries (Europe) B.V.NetherlandsJI
Janssen-Cilag International N.VSpainJC
JANSSEN CILAG INTERNATIONAL NVFrancePC
Pfizer CentreOneUnited States1/2 페이지